ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025
A Pill That Prints-An Ingestible Bioprinter for Non-Invasive Structured Bioink Deposition.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Intraluminal bioink robotic patch deposition system for complex perianal fistulas in Crohn's disease.Annals of medicine and surgery (2012) · 2026Article
- A Pill That Prints-An Ingestible Bioprinter for Non-Invasive Structured Bioink Deposition.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
A foundational demonstration of a tetherless, ingestible bioprinter capable of controlled bioink deposition and patterning for potential applications in endoluminal tissue repair is presented. This ingestible microdevice, the first-of-its-kind, operates without tethers or onboard electronics and is guided using external imaging and magnetic actuation. By integrating near-infrared triggering and magnetic guidance, both applied from outside the body, the ability to guide the pill over target sites and deposit bioink in defined patterns, for ulcer coverage or hemorrhage sealing in ex vivo models is demonstrated. To enable this, the interplay is modeled and optimized between magnetic forces and stick-slip dynamics at the tissue interface, facilitating predictable surface-mediated navigation and patterning. In vivo studies in rabbit models showcase the technical feasibility of deployment, positioning, and controlled extrusion under fluoroscopic guidance. This work thus establishes core engineering principles for future development of non-invasive and untethered endoluminal bioprinting systems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.